EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

KIF1B Regulates NLRP3 ‐Mediated Pyroptosis in Asthma Progression

Junchao Wang, Yuan Gao, Jing Li iD, Chiqiu Jiang

Journal of Cellular and Molecular Medicine · 2025

DOI: 10.1111/jcmm.70975 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Junchao Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, the Third People's Hospital of Hubei Province, Hubei Province, China. Hauptthemen laut MEDLINE: Pyroptosis, Asthma, NLR Family, Pyrin Domain-Containing 3 Protein, Kinesins. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Asthma is a chronic inflammatory respiratory disorder triggered by allergens or environmental pollutants, characterised by airway obstruction, increased airway resistance and breathing difficulties. Although substantial progress has been made in elucidating its pathophysiology, the molecular mechanisms underlying asthma progression remain incompletely understood, and no curative therapies are currently available. The present study explored the role of KIF1B (kinesin family member 1B) in asthma pathogenesis using integrated approaches involving human cohort datasets, in vitro airway epithelial cell models and an in vivo ovalbumin (OVA)‐induced asthma mouse model. KIF1B knockdown and NLRP3 (NLR family pyrin domain‐containing 3) overexpression assays were performed to delineate the molecular mechanisms by which KIF1B modulates pyroptosis. Results showed that KIF1B expression was markedly elevated in bronchial biopsies from asthma patients, OVA‐challenged mouse lungs and IL‐13–stimulated BEAS‐2B cells. Silencing KIF1B significantly attenuated OVA‐ and IL‐13–induced oxidative stress, proinflammatory cytokine release and pulmonary injury. Specifically, KIF1B knockdown reduced the expression of pyroptosis‐associated proteins—NLRP3, cleaved caspase‐1 and cleaved gasdermin D (GSDMD)—while decreasing TNF‐α, IL‐1β and IL‐18 levels and restoring the anti‐inflammatory cytokine IL‐10. Mechanistically, NLRP3 overexpression abolished the anti‐inflammatory and cytoprotective effects of KIF1B silencing, confirming that KIF1B promotes asthmatic inflammation through activation of the NLRP3 inflammasome. In conclusion, these findings identify KIF1B as a key regulator of airway inflammation and pyroptosis in asthma via NLRP3‐dependent signalling. Targeting KIF1B may therefore represent a promising therapeutic strategy for controlling asthma progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyroptosisAsthmaNLR Family, Pyrin Domain-Containing 3 ProteinKinesinsAnimalsHumansMiceDisease ProgressionDisease Models, AnimalFemaleMaleCytokinesCell Line

Stichwörter der Autor:innen

KIF1BNLRP3 inflammasomeairway inflammationasthmapyroptosis

Substanzen

NLR Family, Pyrin Domain-Containing 3 ProteinKinesinsNLRP3 protein, humanCytokines

Autor:innen und Institutionen

  • Department of Pediatrics, the Third People's Hospital of Hubei Province, Hubei Province, China.

ORCID-Profile: Jing Li

Zitieren

APA

Wang, J., Gao, Y., Li, J., & Jiang, C. (2025). KIF1B Regulates NLRP3 ‐Mediated Pyroptosis in Asthma Progression. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70975

Vancouver

Wang J, Gao Y, Li J, Jiang C. KIF1B Regulates NLRP3 ‐Mediated Pyroptosis in Asthma Progression. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70975

BibTeX
@article{Wang2025,
  author = {Wang, Junchao and Gao, Yuan and Li, Jing and Jiang, Chiqiu},
  title = {KIF1B Regulates NLRP3 ‐Mediated Pyroptosis in Asthma Progression},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2025},
  doi = {10.1111/jcmm.70975}
}
Kostenlos starten →